Devoted to Better Health, Naturally

At OliVentures we are driven by a passion to discover natural products that have the potential to benefit human health. Founded in 2009, our goal was (and continues to be) to develop products based on the key elements of the Mediterranean diet, mainly olive oil polyphenols and omega-3 fatty acids, the 2 key staples of the Mediterranean diet that contribute to the health benefits associated with the diet.

OliVentures, working with scientific advisors from Duke University in Durham, North Carolina, operational and medical partners in Spain, and laboratories in the U.S., has successfully isolated and performed preclinical trials of key olive polyphenols found in extra-virgin olive oil. In laboratory trials, OliVentures’ hydroxytyrosol- and tyrosol-laden patented olive fruit extract, called Trephenol™, in some cases replicated third-party scientific studies that point to the potential health benefits of olive polyphenols.

OliVentures’ first product, PureVida™, is a patent-pending combination of Trephenol™ olive fruit extract, Curcumin C3 Complex® (Sabinsa Corporation), and a custom blend of marine omega-3 fatty acids.

Dr. Michael Morse, OliVentures’ Chief Medical Officer, in conjunction with a medical team in Spain, developed the formulation for PureVida™ based on the company’s preclinical research on Trephenol™ and third-party evidence as to the potential benefits of coupling Trephenol™ with marine omega-3s and high-purity curcumin. The team believes that the formulation has the potential to support the body's response to inflammation

The clinical trial conducted by OliVentures in Spain (with 45 patients) sought to demonstrate that the unique combination of natural ingredients in PureVida™ can lower C-reactive protein (CRP) levels. CRP is a marker of inflammation produced by the liver and other organs in response to the release of certain pro-inflammatory substances by immune cells following injury or infection and other conditions associated with tissue injury and inflammation. The trial results demonstrated reduced levels of CRP and a reduction in joint pain in women taking aromatase inhibitors. Because only one trial, with 45 participants, has been performed (and the results have not yet been peer reviewed), more research is needed to confirm that the results of the one trial are valid.a

Trephenol™ Is OliVentures’ Foundational Ingredient

Trephenol™ olive fruit extract is OliVentures’ patented and tested blend of 2 of the extensively studied polyphenols in olive oil: hydroxytyrosol and tyrosol.

Trephenol™ is

  • 100% natural
  • Chemical- and pesticide-free
  • Extracted from high-quality Spanish olives that are non-GMO
    (non-genetically modified organisms)
  • Made using patented clean technology and recovered with water

Scientific Advisors

Michael A. Morse, MD – Medical Director, Scientific Advisor

Professor of Medicine, Professor in the Department of Surgery

Member of the Duke Cancer Institute
Duke University, Raleigh, NC

Research expertise includes the development of targeted therapies, including immunotherapies for solid tumors. He is an Associate Editor for the journal Clinical Cancer Research and has been the principal investigator for a number of Phase 1 and 2 clinical trials.

Prof. Luis Madero, MD, PhD − Scientific Advisor

Head of Oncohematology, University Hospital Niño Jesus, Madrid, Spain

Professor at Universidad Autónoma, Madrid, Spain

President, Asociación Española de Pediatría (Spanish Association of Pediatrics)

Member of the National Academy of Medicine. Performed the first cord blood transplant in Spain. Head of several national medical advisory committees. Extensively published in multiple scientific journals and is author of several medical texts.

Francesco Visioli, PhD −
Scientific Advisor

Senior Investigator, Madrid Institute for Advanced Studies (IMDEA)-Food

Editor in Chief, PharmaNutrition 
University of Padova, Padova, Italy

Member of the European Food Safety Association (EFSA) expert panel.

Discovered biologic and pharmacologic properties of phenols in olive oil. He has published more than 190 scientific articles and has been cited more than 5200 times (H-index=42).

Feel the Benefits of the PureVida Power of 3™

• Supports Heart, Breast, and Joint Health*

• Clinically evaluateda

• Formulation patent-pending

aIn a prospective, multicenter, pilot study of 45 postmenopausal women (mean age 59 years) with Stage 0-IIIA hormone receptor−positive breast cancer receiving stable doses of adjuvant aromatase inhibitor therapy for 2 to 5 years from their diagnosis, PureVida™ significantly reduced C-reactive protein (CRP) levels (p<0.05). In 45 patients examined for safety, reported adverse events (AEs) included abdominal pain in 1 patient (2.2%), constipation in 5 patients (11.1%), headache in 3 patients (6.7%), and abnormal product taste (fish taste) in 14 patients (31.1%). No patients had to discontinue therapy due to AEs. This study was conducted by OliVentures. There has been substantial separate research into the potential benefits of each of the ingredients in PureVida™. The PureVida™ trial has not been peer reviewed and more research is needed before drawing any final conclusions.

*This product is not intended to diagnose, treat, cure, or prevent any disease. Supportive but not conclusive research shows that consumption of EPA and DHA omega-3 fatty acids may reduce the risk of coronary heart disease. Limited clinical evidence indicates that PureVida™ may lower elevated CRP levels. CRP is one of several markers of inflammation in the body. Limited clinical evidence indicates that PureVida™ may reduce joint pain in women taking aromatase inhibitors. These statements have not been evaluated by the U.S. Food and Drug Administration (FDA).